CMS Final Rule Maintains Separate Payment for Diagnostic Imaging Agents
The rule confirms PYLARIFY TruVu’s transitional pass-through status through September 30, 2029, and HCPCS code A9613 is now in effect.
Story updates
12:16:58 PM UTC
SquawkNews
CMS's CY2027 final rule maintains separate payment for qualifying diagnostic radiopharmaceuticals and confirms PYLARIFY TruVu's Transitional Pass-Through status through September 30, 2029. Permanent HCPCS code A9613 took effect October 1, 2026.Material DetailsContext by AI AnalystThis is a reimburs…
12:18:38 PM UTC
SquawkNews
CMS finalized continued separate payment for qualifying diagnostic radiopharmaceuticals in the hospi